Dr. Chabra is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
125 W Hague Rd
Ste 180
El Paso, TX 79902Phone+1 915-317-1660Fax+1 915-320-4848- Is this information wrong?
Education & Training
- University of California (Irvine)Fellowship, Rheumatology, 2006 - 2008
- University of Arizona College of Medicine-PhoenixResidency, Internal Medicine, 2002 - 2005
- College of Osteopathic Medicine of the PacificClass of 2002
Certifications & Licensure
- CA State License 2006 - 2024
- TX State License 2018 - 2024
- AZ State License 2004 - 2023
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification Allscripts Enterprise EHR, Allscripts, 2011-2012
- Fellow American College of Rheumatology
Publications & Presentations
PubMed
- Satisfaction with the Injection Experience of a New, Citrate-Free Formulation of Ixekizumab.Sanjay Chabra, Julie Birt, Rebecca Bolce, Jeffrey Lisse, William N Malatestinic, Baojin Zhu, Miriam Kimel, Julie McCormack, Marissa Stefan, W Chad Cragun> ;Advances in Therapy. 2024 Apr 1
- 13 citationsIxekizumab Citrate-Free Formulation: Results from Two Clinical Trials.Sanjay Chabra, B J Gill, Gaia Gallo, Danting Zhu, Celine Pitou, Christopher D Payne, Ana Accioly, Luis Puig> ;Advances in Therapy. 2022 Jun 1
- 38 citationsCervical cancer with paraaortic metastases: significance of residual paraaortic disease after surgical staging.Peter Y. Kim, Bradley J. Monk, Sanjay Chabra, Robert A. Burger, Steven A. Vasilev, Alberto Manetta, Philip J. DiSaia, Michael L. Berman> ;Gynecologic Oncology. 1998 Jun 1
Press Mentions
- RINVOQ® (Upadacitinib) Has Remission Data, with or Without Methotrexate1-3August 1st, 2022
Hospital Affiliations
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: